Agency Forms Undergoing Paperwork Reduction Act Review, 2525-2526 [2019-01326]
Download as PDF
2525
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Barriers and Facilitators to Expanding
the NHBS to Conduct HIV Behavioral
Surveillance Among Transgender
Women (NHBS-Trans)—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National HIV Behavioral
Surveillance System (NHBS, OMB No.
0920–0770, exp. 5/31/2020) is CDC’s
ongoing surveillance system to assess
HIV prevalence and factors associated
with HIV among populations at high
risk for HIV. NHBS has a 15-year record
of successfully reaching and recruiting
hidden populations, with a focus on
men who have sex with men, injection
drug users, and heterosexuals at high
risk of HIV infection.
CDC requests OMB approval to
conduct a two-year pilot study to
examine the feasibility of extending the
NHBS’s proven surveillance framework
to include transgender (TG) women, a
hidden subpopulation with a
disproportionately high burden of HIV.
Information will be collected in nine
geographically diverse U.S.
Metropolitan Statistical Areas (MSAs)
with high HIV prevalence: Atlanta, GA,
Dallas, TX, Los Angeles, CA, New
Orleans, LA, New York, NY,
Philadelphia, PA, San Francisco, CA,
Seattle, WA, and Washington, DC.
Together these sites accounted for over
33% of all persons living with HIV at
year end 2014 in large (>500,000
residents) MSAs. All NHBS-Trans sites
currently participate in the NHBS and
are familiar with its protocols for
respondent recruitment, information
collection, HIV testing, and referral to
services.
The NHBS-Trans pilot study will use
customized NHBS instruments,
sampling and recruitment methods to
assess barriers to, and best strategies for,
conducting HIV-related bio-behavioral
surveys among transgender women.
Information will be collected on HIV
risk behaviors, gaps in services, barriers
to service, and other experiences of
transgender women from racial and
ethnic minority populations. Potential
participants will be identified through
respondent-driven recruitment methods,
also called peer-based recruitment.
During the two-year information
collection period, each NHBS-Trans site
will recruit 200 respondents for a
computer-assisted personal interview.
The proposed respondents are adult
minority transgender women. After
completing the 40-minute interview,
each respondent will be offered a free,
rapid HIV test. Respondents will also be
asked to participate in short debriefing
interviews about their experiences with
recruiting additional participants. The
debriefing interviews will help CDC
understand the reasons why eligible
transgender women choose not to
participate in the NHBS-Trans pilot
study.
Over the two-year pilot period, the
target number of completed interviews
for all sites is 1,800 (200 per site). CDC
estimates that 1,980 individuals must be
screened in order to identify 1,800
individuals who meet eligibility criteria
and consent to participation.
Quantitative analysis of 1,800
interviews will be conducted using
SAS. Findings of the NHBS-Trans pilot
study will be used by CDC and local
health department staff to assess the
feasibility of using NHBS infrastructure
to monitor the prevalence of HIV among
transgender women of color and to
strengthen understanding of the
behavioral and environmental HIV risk
factors that contribute to the
disproportionately high prevalence of
HIV within this population. Improved
surveillance of transgender women is
necessary to help CDC and health
departments identify areas for
community-level interventions, track
the progress of communities in
implementing change, and evaluate
interventions that seek to reduce HIV
risk factors and increase engagement in
HIV prevention and care.
Participation in the NHBS-Trans
study is voluntary and there are no costs
to respondents other than their time.
The total estimated annualized burden
hours are 713.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form
name
Number of
respondents
Transgender Women >18 years old ...............
Eligible and consenting participants ...............
Peer Recruiters ...............................................
Eligibility Screener ..........................................
NHBS-Trans Interview ...................................
Recruiter Debriefing Form ..............................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–01322 Filed 2–6–19; 8:45 am]
[30-Day–19–0210]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled List of
Ingredients Added to Tobacco in the
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
990
900
900
Number of
responses per
respondent
1
1
1
Average
burden per
response
(in hours)
5/60
40/60
2/60
Manufacture of Cigarette Products to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 21, 2018 to obtain
comments from the public and affected
agencies. CDC received 2 comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
E:\FR\FM\07FEN1.SGM
07FEN1
2526
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
List of Ingredients Added to Tobacco
in the Manufacture of Cigarette Products
(OMB No. 0920–0210, Expiration Date
12/31/2018)—Reinstatement with
Change—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Cigarette smoking is the leading
preventable cause of premature death
and disability in our Nation. Each year
more than 480,000 deaths occur as the
result of cigarette smoking–related
diseases. The CDC, Office on Smoking
and Health (OSH), has the primary
responsibility for the HHS smoking and
health program. Since 1986, as required
by the Comprehensive Smoking
Education Act of 1984, which amended
the Federal Cigarette Labeling and
Advertising Act, 15 U.S.C. 1335a, CDC
has collected information about the
ingredients used in cigarette products.
Respondents are commercial cigarette
manufacturers, packagers, or importers
(or their representatives), who are
required by the CSEA to submit
ingredient reports to HHS on an annual
basis. Respondents are not required to
submit specific forms; however, they are
required to submit a list of all
ingredients used in their products. CDC
requires the ingredient report to be
submitted by chemical name and
Chemical Abstract Service (CAS)
Registration Number, consistent with
accepted reporting practices for other
companies currently required to report
ingredients added to other consumer
products.
Ingredient reports are due annually on
March 31. Information is submitted to
CDC by mailing or faxing a written
report on the respondent’s letterhead.
All faxed lists should be followed up
with a mailed original. Data may also be
submitted to CDC by CD, three-inch
floppy disk, or thumb drive. Electronic
mail submissions are not accepted. Mail
Annual Ingredient Submissions to
Attention: FCLAA Program Manager,
Office on Smoking and Health, National
Center for Chronic Disease Prevention
and Health Promotion, Centers for
Disease Control and Prevention, 4770
Buford Highway NE, MS S107–7,
Atlanta, GA 30341–3717.
Upon receipt and verification of the
annual ingredient report, OSH issues a
Certificate of Compliance to the
respondent. CDC also uses the
information to report to Congress (as
deemed appropriate) discussing the
health effects of these ingredients. There
are no costs to respondents other than
their time. The total estimated
annualized burden hours are 358. OMB
approval is requested for three years.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Business Entities .............................................................................................
N/A
55
1
6.5
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–01326 Filed 2–6–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Survey of Head Start Grantees
on Training and Technical Assistance
(New Collection)
Office of Planning, Research,
and Evaluation; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) at the U.S.
Department of Health and Human
Services (HHS) seeks approval to
conduct a statistically representative
SUMMARY:
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
survey of directors and managers/
coordinators from Head Start grantee
organizations regarding their access to
and use of training and technical
assistance (T/TA) from multiple
sources, including ACF’s Early
Childhood Training and Technical
Assistance system. The purpose of the
data collection is to inform ACF on
three aspects of grantee directors and
managers/coordinators T/TA
experience: (1) Search and selection of
T/TA; (2) receipt of T/TA; (3) and
potential relationships between T/TA
received and perceived change in
practice.
Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
DATES:
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2525-2526]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01326]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-19-0210]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled List of Ingredients Added to Tobacco in the
Manufacture of Cigarette Products to the Office of Management and
Budget (OMB) for review and approval. CDC previously published a
``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on August 21, 2018 to obtain comments from the
public and affected agencies. CDC received 2 comments related to the
previous notice. This notice serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this proposed information
collection project.
[[Page 2526]]
The Office of Management and Budget is particularly interested in
comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
List of Ingredients Added to Tobacco in the Manufacture of
Cigarette Products (OMB No. 0920-0210, Expiration Date 12/31/2018)--
Reinstatement with Change--National Center for Chronic Disease
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Cigarette smoking is the leading preventable cause of premature
death and disability in our Nation. Each year more than 480,000 deaths
occur as the result of cigarette smoking-related diseases. The CDC,
Office on Smoking and Health (OSH), has the primary responsibility for
the HHS smoking and health program. Since 1986, as required by the
Comprehensive Smoking Education Act of 1984, which amended the Federal
Cigarette Labeling and Advertising Act, 15 U.S.C. 1335a, CDC has
collected information about the ingredients used in cigarette products.
Respondents are commercial cigarette manufacturers, packagers, or
importers (or their representatives), who are required by the CSEA to
submit ingredient reports to HHS on an annual basis. Respondents are
not required to submit specific forms; however, they are required to
submit a list of all ingredients used in their products. CDC requires
the ingredient report to be submitted by chemical name and Chemical
Abstract Service (CAS) Registration Number, consistent with accepted
reporting practices for other companies currently required to report
ingredients added to other consumer products.
Ingredient reports are due annually on March 31. Information is
submitted to CDC by mailing or faxing a written report on the
respondent's letterhead. All faxed lists should be followed up with a
mailed original. Data may also be submitted to CDC by CD, three-inch
floppy disk, or thumb drive. Electronic mail submissions are not
accepted. Mail Annual Ingredient Submissions to Attention: FCLAA
Program Manager, Office on Smoking and Health, National Center for
Chronic Disease Prevention and Health Promotion, Centers for Disease
Control and Prevention, 4770 Buford Highway NE, MS S107-7, Atlanta, GA
30341-3717.
Upon receipt and verification of the annual ingredient report, OSH
issues a Certificate of Compliance to the respondent. CDC also uses the
information to report to Congress (as deemed appropriate) discussing
the health effects of these ingredients. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 358. OMB approval is requested for three years.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Business Entities........................... N/A 55 1 6.5
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-01326 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P